Pleural mesothelioma classification-update and challenges.
Dacic S.
Mod Pathol. 2022 Jan;35(Suppl 1):51-56. doi: 10.1038/s41379-021-00895-7. Epub 2021 Aug 31.
Perspectives on the Treatment of Malignant Pleural Mesothelioma.
Janes SM, Alrifai D, Fennell DA.
N Engl J Med. 2021 Sep 23;385(13):1207-1218. doi: 10.1056/NEJMra1912719.
The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification.
Sauter JL, Dacic S, Galateau-Salle F, Attanoos RL, Butnor KJ, Churg A, Husain AN, Kadota K, Khoor A, Nicholson AG, Roggli V, Schmitt F, Tsao MS, Travis WD.
J Thorac Oncol. 2022 May;17(5):608-622. doi: 10.1016/j.jtho.2021.12.014. Epub 2022 Jan 10.
Pleural neoplastic pathology.
Karpathiou G, Stefanou D, Froudarakis ME.
Respir Med. 2015 Aug;109(8):931-43. doi: 10.1016/j.rmed.2015.05.014. Epub 2015 May 21.
Diagnosis and treatment of malignant pleural mesothelioma.
Rodríguez Panadero F.
Arch Bronconeumol. 2015 Apr;51(4):177-84. doi: 10.1016/j.arbres.2014.06.005. Epub 2014 Jul 22.
Pleurectomy decortication in the treatment of the "trapped lung" in benign and malignant pleural effusions.
Rathinam S, Waller DA.
Thorac Surg Clin. 2013 Feb;23(1):51-61, vi. doi: 10.1016/j.thorsurg.2012.10.007.
Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X, Wei F, Li J, Dai L, Wang X, Jia L, Wang H, An L, Yang Y, Zhang G, Cheng Z.
Clin Respir J. 2018 Mar;12(3):986-990. doi: 10.1111/crj.12615. Epub 2017 Feb 13.
Benign and malignant pleural mesothelioma.
Antman KH, Corson JM.
Clin Chest Med. 1985 Mar;6(1):127-40.
CT appearances of pleural tumours.
Salahudeen HM, Hoey ET, Robertson RJ, Darby MJ.
Clin Radiol. 2009 Sep;64(9):918-30. doi: 10.1016/j.crad.2009.03.010. Epub 2009 Jun 23.
Chemokines in tumor proximal fluids.
Kotyza J.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Mar;161(1):41-49. doi: 10.5507/bp.2016.062. Epub 2017 Jan 6.
